| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $17,970,141 ) (Continued on the next page) |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | U01AI187297 | Dissecting the host-plasmid interplay to unravel the spread of ESBL-producing K. pneumoniae | 000 | 2 | NIH | 6/23/2026 | $862,153 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | UH3OD035546 | Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO) | 001 | 4 | NIH | 7/16/2026 | $5,168,081 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI190958 | Effects of antifungal drug treatment and immune dysfunction on the evolutionary dynamics of gut-colonizing Candida glabrata | 000 | 2 | NIH | 1/26/2026 | $221,375 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI112579 | Regulation of T cell exhaustion via 3D chromatin architecture | 001 | 11 | NIH | 5/4/2026 | $624,311 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA290808 | ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection | 000 | 3 | NIH | 4/27/2026 | $733,555 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 002 | 4 | SAMHSA | 6/26/2026 | $374,129 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2554943 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/21/2026 | $398,569 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | K22CA288932 | Cancer Misinformation and Use of Complementary and Alternative Therapy (CAM) among Patients with Cancer. | 000 | 3 | NIH | 6/11/2026 | $194,400 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI177342 | Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease | 000 | 4 | NIH | 6/1/2026 | $838,280 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI184502 | Shorter and more effective oral regimens for M. abscessus pulmonary disease | 000 | 2 | NIH | 1/28/2026 | $856,988 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 001 | 5 | NIH | 4/16/2026 | $53,945 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R37CA250661 | Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells | 000 | 5 | NIH | 1/26/2026 | $485,503 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI182977 | Tissue specific immunity to fungal infections | 000 | 2 | NIH | 11/26/2025 | $883,729 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI187674 | C25-modified rifabutin analogs as a novel medicinal chemistry strategy to overcome drug-resistant tuberculosis | 000 | 2 | NIH | 1/9/2026 | $221,375 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 02 | 7 | CMS | 6/26/2026 | $0 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 01 | 7 | CMS | 5/14/2026 | $0 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 00 | 7 | CMS | 12/19/2025 | $1,615,000 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI132374 | Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease | 000 | 9 | NIH | 4/21/2026 | $872,777 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21CA309638 | Identifying Predictive and Prognostic Adipome Biomarkers in Obese TNBC Mice for Targeted Therapy Development | 000 | 1 | NIH | 7/16/2026 | $460,254 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA315494 | CLEAR-Lung: Community-Level Effectiveness to Advance Reach in Lung Cancer Screening | 000 | 1 | NIH | 7/17/2026 | $769,923 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21CA293616 | Myeloid Phagocyte Activation by Commensal-Activated Complement C5aR1 Signaling: Implications for Tumor-Directed Lymphocyte Response | 001 | 1 | NIH | 5/7/2026 | $0 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21CA293616 | Myeloid Phagocyte Activation by Commensal-Activated Complement C5aR1 Signaling: Implications for Tumor-Directed Lymphocyte Response | 000 | 1 | NIH | 4/29/2026 | $467,261 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI141805 | Dissecting the molecular targets to overcome beta-lactam resistance in M. abscessus complex | 000 | 6 | NIH | 6/30/2026 | $839,368 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA270252 | Identifying and characterizing functional noncoding mutations in multiple myeloma | 000 | 4 | NIH | 3/9/2026 | $706,026 |
| | 2026 | 2026 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA283566 | Nuclear envelope and predisposition to hepatic neoplasia | 000 | 5 | NIH | 7/7/2026 | $405,116 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 004 | 2 | NIH | 6/2/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | UH3OD035546 | Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO) | 000 | 3 | NIH | 4/22/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 001 | 3 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI083671 | HMH Youth and Family TREE Program | 000 | 3 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | T2554943 | Addiction Medicine Fellowship | 02 | 1 | HRSA | 3/5/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 002 | 5 | SAMHSA | 5/12/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 001 | 5 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79SM084539 | Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) | 000 | 5 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI084385 | I.C.A.R.E. - Integrated Care for Addiction Recovery Expansion | 001 | 5 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | H79TI084385 | I.C.A.R.E. - Integrated Care for Addiction Recovery Expansion | 000 | 5 | SAMHSA | 1/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI161013 | Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection | 000 | 5 | NIH | 4/2/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA254274 | Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy | 000 | 6 | NIH | 5/12/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | 2B2CMS331786 | Integrated Care for Kids (InCK) | 02 | 6 | CMS | 10/16/2025 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 002 | 2 | NIH | 3/13/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 000 | 2 | NIH | 2/23/2026 | -$442,750 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 005 | 2 | NIH | 6/4/2026 | $0 |
| | 2026 | 2025 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01NS133233 | Neutrophil extracellular traps and associated pathogenesis in TBI: a novel peptide therapeutic strategy. | 003 | 2 | NIH | 6/1/2026 | $442,750 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI112579 | Regulation of T cell exhaustion via 3D chromatin architecture | 000 | 9 | NIH | 1/20/2026 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R21AI168729 | Elucidating mediators of genetic instability in Candida glabrata | 000 | 2 | NIH | 4/21/2026 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI150765 | Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue | 000 | 6 | NIH | 5/14/2026 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | UG3OD035546 | Enriching ECHO Cohorts with High-risk Pregnancies and Children with Disabilities (Enriching ECHO) | 000 | 2 | NIH | 11/18/2025 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01AI109025 | Critical Factors Influencing Echinocandin Resistance in Candida glabrata | 000 | 12 | NIH | 1/20/2026 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R01CA263662 | Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations | 000 | 4 | NIH | 1/15/2026 | $0 |
| | 2026 | 2024 | HMH HOSPITALS CORPORATION | 343 THORNALL ST | EDISON | NJ | 08837-2206 | MIDDLESEX | USA | R00CA245488 | Leveraging behavioral science to improve patient understanding of advanced cancer | 000 | 5 | NIH | 5/1/2026 | -$43,745 |
|
